News Focus
News Focus
Followers 4
Posts 303
Boards Moderated 0
Alias Born 04/04/2024

Re: BIOChecker4 post# 515332

Monday, 03/09/2026 9:16:58 AM

Monday, March 09, 2026 9:16:58 AM

Post# of 516071
Maybe Blarca. is a great drug, just that with hundreds rather than thousands of trial participants I don't believe it will be approved without another full P3 trial to prove efficacy. I agree with you and the odds of EMA approval are at best 20-25% conditionally. Anavex/Missling sat on their hands doing nothing when another trial was called for, 1000 plus participants. I messed up by investing but no longer believe in them. At all. ANNX far better shot but not ALZ.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News